Orthopaedic Research Laboratory, Department of Orthopaedic Surgery and Traumatology, Odense University Hospital, Department of Clinical Research, University of Southern Denmark, Sdr. Boulevard 29, DK-5000 Odense, Denmark.
Department of Orthopaedic Surgery and Traumatology, Slagelse Hospital, Region Zealand, Denmark.
Biomed Res Int. 2021 Mar 3;2021:6676609. doi: 10.1155/2021/6676609. eCollection 2021.
Mesenchymal stem cells (MSCs) and vascular endothelial growth factor (VEGF) are key factors in bone regeneration. Further stimulation should establish an enhanced cell environment optimal for vessel evolvement and hereby being able to attract bone-forming cells. The aim of this study was to generate new bone by using MSCs and VEGF, being able to stimulate growth equal to allograft.
Eight Texel/Gotland sheep had four titanium implants in a size of 10 × 12 mm inserted into bilateral distal femurs, containing a 2 mm gap. In the gap, autologous 3 × 10 MSCs seeded on hydroxyapatite (HA) granules in combination with 10 ng, 100 ng, and 500 ng VEGF release/day were added. After 12 weeks, the implant-bone blocks were harvested, embedded, and sectioned for histomorphometric analysis. Bone formation and mechanical fixation were evaluated. Blood samples were collected for the determination of bone-related biomarkers and VEGF in serum at weeks 0, 1, 4, 8, and 12.
The combination of 3 × 10 MSCs with 10 ng, 100 ng, and 500 ng VEGF release/day exhibited similar amount of bone formation within the gap as allograft ( > 0.05). Moreover, no difference in mechanical fixation was observed between the groups ( > 0.05). Serum biomarkers showed no significant difference compared to baseline (all > 0.05).
MSCs and VEGF exhibit significant bone regeneration, and their bone properties equal to allograft, with no systemic increase in osteogenic markers or VEGF with no visible side effects. This study indicates a possible new approach into solving the problem of insufficient allograft, in larger bone defects.
间充质干细胞(MSCs)和血管内皮生长因子(VEGF)是骨再生的关键因素。进一步的刺激应该建立一个增强的细胞环境,最适合血管的演变,并由此能够吸引成骨细胞。本研究的目的是通过使用 MSC 和 VEGF 生成新骨,能够刺激与同种异体移植物相等的生长。
8 只 Texel/Gotland 绵羊在双侧股骨远端植入 4 个 10×12mm 的钛植入物,植入物之间留有 2mm 的间隙。在该间隙中,加入 3×10 个自体 MSC 接种在羟基磷灰石(HA)颗粒上,并结合每天释放 10ng、100ng 和 500ng 的 VEGF。12 周后,取出植入物-骨块,进行包埋和切片,进行组织形态计量学分析。评估骨形成和机械固定。在 0、1、4、8 和 12 周时采集血液样本,以测定血清中的骨相关生物标志物和 VEGF。
3×10 MSC 与每天释放 10ng、100ng 和 500ng 的 VEGF 组合在间隙内表现出与同种异体移植物相似的骨形成量(>0.05)。此外,各组之间的机械固定没有观察到差异(>0.05)。与基线相比,血清生物标志物没有显著差异(均>0.05)。
MSC 和 VEGF 表现出显著的骨再生,其骨性能与同种异体移植物相当,没有系统增加成骨标志物或 VEGF,没有明显的副作用。本研究表明,在较大的骨缺损中,解决同种异体移植物不足的问题可能有新的方法。